ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response

[1]  Wei Zhang,et al.  The Protective Effects of Beta-Casomorphin-7 against Glucose -Induced Renal Oxidative Stress In Vivo and Vitro , 2013, PloS one.

[2]  M. Barton.  Prevention and endothelial therapy of coronary artery disease. , 2013, Current opinion in pharmacology.

[3]  K. Varner,et al.  Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy , 2012, PloS one.

[4]  H. Itoh,et al.  [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[5]  A. Çelik,et al.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease , 2012, Clinical Research in Cardiology.

[6]  F. Gao,et al.  Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[7]  S. Homer-Vanniasinkam,et al.  The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease , 2012, Cardiology research and practice.

[8]  Merlin C. Thomas,et al.  Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications , 2012, Journal of hypertension.

[9]  Jennifer A. Johnson,et al.  ACE2 Improves Right Ventricular Function in a Pressure Overload Model , 2011, PloS one.

[10]  S. Sriramula,et al.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  H. Kuhn,et al.  Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. , 2011, Atherosclerosis.

[12]  W. Burns,et al.  Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease , 2011, Current opinion in nephrology and hypertension.

[13]  Jun Ren,et al.  Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs. , 2010, Toxicology letters.

[14]  D. Casley,et al.  Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E–Deficient Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Rajesh Kumar,et al.  Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis , 2008, Diabetes.

[16]  Arthur S Slutsky,et al.  Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. , 2008, American journal of physiology. Heart and circulatory physiology.

[17]  Bin Liu,et al.  Overexpression of ACE2 Enhances Plaque Stability in a Rabbit Model of Atherosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[18]  T. Ha,et al.  Epigallocatechin-3-O-Gallate Inhibits the Angiotensin II-Induced Adhesion Molecule Expression in Human Umbilical Vein Endothelial Cell Via Inhibition of MAPK Pathways , 2007, Cellular Physiology and Biochemistry.

[19]  Rajesh Kumar,et al.  The intracellular renin–angiotensin system: a new paradigm , 2007, Trends in Endocrinology & Metabolism.

[20]  E. Schiffrin,et al.  Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways , 2007, Hypertension.

[21]  Z. Su,et al.  Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. , 2006, Kidney international.

[22]  Yao Sun,et al.  Angiotensin 1-7 promotes cardiac angiogenesis following infarction. , 2015, Current vascular pharmacology.

[23]  Merlin C. Thomas,et al.  Angiotensin converting enzyme 2 and atherosclerosis. , 2013, Atherosclerosis.